Wed, Mar 4, 2015, 8:10 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • chimakot chimakot Feb 14, 2013 6:10 PM Flag

    Very good seeking alpha article released after the bell.

    It's an interview with a noted expert in this sector. Read it, it's worth the time.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • TLSR: Could we talk about some companies? Go ahead with an idea.

      RS: At this juncture, we are looking primarily at companies with significant value-driving catalysts this year. One of these is antibiotic developer Trius Therapeutics Inc. (TSRX). We have been bullish on Trius for quite some time. It recently raised capital; it is very well-funded. It is highly unlikely that there will be an additional near-term dilutive capital raise. We think investors should take a look at this company now, and consider this a reasonable and timely entry point.

      TLSR: Go ahead and talk about the catalyst. When is it anticipated?

      RS: It is expected to occur in the second half of March, with the release of top-line data from a second phase 3 trial of the company's novel antibiotic, tedizolid phosphate, a member of the oxazolidinone family. This is a confirmatory trial for skin structure infections. Since the designs of the first phase 3 trial and this one are virtually identical, we believe the second trial will be positive as well. We are very enthusiastic about the upcoming data release.

13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Vivint Solar, Inc.
NYSEWed, Mar 4, 2015 4:01 PM EST
Wayfair Inc.
NYSEWed, Mar 4, 2015 4:02 PM EST